Autologous stem cell transplantation for myocardial repair.
Current therapies for heart failure due to transmural left ventricular (LV) infarction are limited. We have developed a novel patch method for delivering autologous bone marrow stem cells to sites of myocardial infarction for the purpose of improving LV function and preventing LV aneurysm formation. The patch consisted of a fibrin matrix seeded with autologous porcine mesenchymal stem cells labeled with lacZ. We applied this patch to a swine model of postinfarction LV remodeling. Myocardial infarction was produced by using a 60-min occlusion of the left anterior descending coronary artery distal to the first diagonal branch followed by reperfusion. Results were compared between eight pigs with stem cell patch transplantation, six pigs with the patch but no stem cells (P), and six pigs with left anterior descending coronary artery ligation alone (L). Magnetic resonance imaging data collected 19 +/- 1 days after the myocardial infarction indicated a significant increase of LV systolic wall thickening fraction in the infarct zone of transplanted hearts compared with P or L hearts. Blue X-gal staining was observed in the infarcted area of transplanted hearts. PCR amplification of specimens from the X-gal-positive area revealed the Ad5 RSV-lacZ vector fragment DNA sequence. Light microscopy demonstrated that transplanted cells had differentiated into cells with myocyte-like characteristics and a robust increase of neovascularization as evidenced by von Willebrand factor-positive angioblasts and capillaries in transplanted hearts. Thus this patch-based autologous stem cell procedure may serve as a therapeutic modality for myocardial repair.
Liu
Jingbo
J
Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Hu
Qingsong
Q
Wang
Zongli
Z
Xu
Chengsu
C
Wang
Xiaohong
X
Gong
Guangrong
G
Mansoor
Abdul
A
Lee
Joseph
J
Hou
Mingxiao
M
Zeng
Lepeng
L
Zhang
John R
JR
Jerosch-Herold
Michael
M
Guo
Tao
T
Bache
Robert J
RJ
Zhang
Jianyi
J
D000818:Animals; D002454:Cell Differentiation; D002465:Cell Movement; D002478:Cells, Cultured; D005337:Fibrin; D008648:Mesoderm / Q000166:cytology; D009203:Myocardial Infarction / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery*; D032383:Myocytes, Cardiac / Q000166:cytology; D018919:Neovascularization, Physiologic; D010641:Phenotype; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology / Q000502:physiology; D013552:Swine; D014161:Transduction, Genetic; D014182:Transplantation, Autologous; D014945:Wound Healing
D005337:Fibrin